UNITED ~~STATES~~STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT ~~REPORT~~ REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~Pursuant~~May to7, ~~Section~~2015Date 13of orReport 15(d)Date of ~~the~~earliest ~~Securities~~event ~~Exchange Act of 1934~~reported)

February 28, 2015

Date of Report (Date of earliest event reported)

NANO LABS CORP.

(Exact name of registrant as specified in its charter)

Colorado	333-171658	84-1307164
(State or other jurisdictionof incorporation)	(CommissionFile Number)	(IRS EmployerIdentification No.)
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

The Ford Building615 Griswold Street, 17th FloorSuite 1715Detroit, Michigan		48226
The Ford Building 615 Griswold Street, 17th Floor Suite 1715 Detroit, Michigan		48226
(Address of principal executive offices)		(Zip Code)

(888) 806-~~2315~~2315Registrant’s telephone number, including area code

Registrant’s telephone number, including area code

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~SECTION~~¨ 1.Soliciting ~~REGISTRANT’S~~material ~~BUSINESS~~pursuant ~~AND~~to ~~OPERATIONS~~Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

~~ITEM~~¨ ~~1.01~~Pre-commencement ~~ENTRY~~communications ~~INTO~~pursuant Ato ~~MATERIAL~~Rule ~~DEFINITIVE~~14d-2(b) ~~AGREEMENT~~under the Exchange Act (17 CFR 240.14d-2(b))

~~ET3M~~¨ ~~Group~~Pre-commencement ~~Joint~~communications ~~Venture~~pursuant ~~Collaboration~~to ~~Agreement~~Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

OnSECTION ~~February~~4 28, 2015, the Board of Directors of Nano Labs Corp., a Colorado corporation (the “Company”), entered into that certain joint venture collaboration agreement dated February 28, 2015 for a term of ten years (the "ET3M Joint Venture Agreement") with The ET3M Group ("ET3M"), for the manufacture, distribution and commercialization of ET3M's technology consisting of an electronic circuit capable of multiplying, through a process of electronic reasonance, the output of any existing standard electric power source (the "Technology"). ET3M is a technology based company presently located in Mexico which has researched and developed the Technology, which further consists of the harvesting of energy already present in the subatomic quantium fields of all matter and which is always present in infintie quantity in all of the surrounding environment, and with its addition to the Technology will harvest and generate such energy. Management of the Company has entered into discussions with ET3M regarding application of the Technology to electronic circuits capable of generating remarkable power-~~savings~~ ~~when~~MATTERS ~~connected~~RELATED toTO ~~industrial~~ACCOUNTANTS ~~electric~~AND ~~induction~~FINANCIAL motors, owned and used at industrial plants by large international corporations (the "Power Multiplication Circuits"). Management believes that in the event ET3M develops the Power Multiplication Circuits, which would be specifically and exclusively applied to distributed power multiplication with the centralized power generation systems market, would present great business potential in the commercialization of such Power Multiplication Circuits and/of the excess energy obtained through their use.STATEMENTS

~~Therefore,~~ITEM ~~the parties entered into the ET3M Joint Venture Agreement~~4.01 ~~The~~CHANGES ~~general~~IN ~~purpose of the ET3M Joint Venture Agreement is to: (i) design, develop, testing, manufacture and commercialize exclusively for the U.~~REGISTRANT'S. ~~and~~CERTIFYING Canadian markets the Power Multiplication Circuits in the application for distributed power multiplication within the centralized power generation systems market; (ii) exploit market opportunities based on the Technology and the Power Multiplication Circuits; (iii) to provide fulfillment funding through the Company to design, scale-up, test, obtain certifications, construct, assemble, produce and market the Power Multiplication Circuits for the harvest and use of energy in the environment and specifically in its application within the centralized power generation systems market; and (iv) to establish a joint venture entity (the "Joint Venture Company" between the Company and ET3M called "B3 Labs" for operational and funding requirements pertaining to the purposes above.ACCOUNTANT

InNano ~~accordance~~Labs ~~with~~Corp., ~~the~~a ~~terms~~Colorado ~~and~~corporation ~~provisions of~~ (the ~~ET3M~~"Company") ~~Joint~~reports ~~Venture~~in ~~Agreement,~~this ~~the~~Current ~~parties~~Report ~~agreed~~on ~~that~~Form ~~certain~~8-K ~~contracts~~a change in ~~acceptable~~certifying ~~form~~accountants. ~~would~~Effective beMay ~~entered~~7, ~~into~~2015, asthe ~~follows:~~Company's ~~(i)~~certifying aaccountant, ~~technology~~Terry orL. ~~license~~Johnson, ~~agreement~~CPA ~~regarding the Technology;~~ (ii"Johnson"), awas ~~manufacturing~~dismissed ~~contract~~as ~~between~~the ~~manufacturers~~Company's ~~and~~independent ~~the~~registered ~~Joint~~public ~~Venture~~accounting ~~Company~~firm. ~~for~~The ~~the~~Company ~~exclusive~~has ~~manufacturing~~engaged ~~and~~Malone ~~assembly~~Bailey ofLLP ~~parts;~~ (~~iii~~"MB") aas ~~trademark~~its ~~license~~principal ~~agreement~~independent ~~between~~registered ~~ET3M~~public ~~and~~accounting ~~the~~firm ~~Joint~~effective ~~Venture~~May ~~Company~~7, ~~for~~2015. ~~licensing~~The ofdecision ~~the~~to ~~use~~change ofits ~~the~~principal ~~products~~independent ~~and~~registered ~~trademarks~~public ~~associated~~accounting ~~with~~firm ~~the~~has ~~Technology;~~been ~~and~~approved ~~(iv)~~by ~~assignment agreements between ET3M and~~ the Company’s ~~regarding~~board ~~the~~of ~~Technology~~directors.

InThe ~~further~~reports ~~accordance~~of ~~with~~Johnson on the ~~terms~~Company’s ~~and~~financial ~~provisions~~statements offor ~~the~~fiscal ~~ET3M~~years ~~Joint~~ended ~~Venture~~June ~~Agreement~~30, ~~the~~2014 ~~parties~~and ~~agreed~~June ~~that~~30, ~~the~~2013 ~~Joint~~(which ~~Venture~~included ~~Company~~the ~~would~~balance besheet ~~established~~as ~~for a period~~ of ~~ten~~June ~~years~~30, ~~ET3M~~2014, and the ~~Company~~statement ~~would~~of ~~each hold a 50% equity interest~~operations, ~~respectively,~~cash flows and astockholders’ ~~four~~equity ~~member~~as ~~board~~ of ~~directors~~June ~~shall~~30, be2014), ~~established~~for ~~with~~either ~~ET3M~~of ~~appointing~~the past two ~~directors~~fiscal ~~and~~years, ~~the~~did ~~Company~~not ~~appointing~~contain ~~two~~an ~~directors~~adverse ~~(and~~opinion ~~the~~or ~~removal~~a disclaimer of ~~any~~opinion, ~~one~~nor ~~director~~qualified ~~shall~~or ~~require~~modified ~~the~~as ~~votes~~to ofuncertainty, ~~three~~audit ~~directors).~~scope ~~ET3M~~or ~~has~~accounting ~~committed~~principles, toother ~~license~~than to ~~the~~state ~~Joint~~that ~~Venture~~there ~~Company~~is ~~the~~substantial ~~Technology~~doubt ~~and~~as ~~ET3M~~to ~~shall~~the ~~further~~ability ~~assist~~of the ~~Joint Venture~~ Company ~~with:~~to ~~(i)~~continue ~~product~~as ~~registration;~~a ~~(ii)~~going ~~efficacy~~concern. ULDuring ~~and~~the ~~ASTM~~Company’s ~~testing~~fiscal ~~and~~years ~~qualifications;~~ended ~~(iii)~~June ~~product~~30, ~~summary~~2014 ~~descriptions~~ and ~~details;~~June ~~(iv)~~30, ~~competitive~~2013 ~~industry~~ and ~~product~~during ~~review;~~the ~~(v)~~subsequent ~~product~~period ~~pricing~~through ~~structure;~~to ~~(vi)~~the ~~market~~date ~~and~~of ~~sales~~Johnson's ~~strategy~~dismissal, ~~and~~there ~~structure;~~were ~~(vii)~~no ~~manufacturing~~disagreements ~~advice~~between tothe ~~produce/connect~~Company ~~samples; (viii) sampling~~ and ~~testing~~Johnson, ~~relating~~whether toor ~~product~~not ~~certification;~~resolved, ~~(ix)~~on ~~laboratory quality control testing; and (x)~~ any ~~and~~matter ~~all relevant staffing and hiring~~ of ~~consultants.~~accounting ~~Both~~principles ~~the~~or ~~Company~~practices, ~~and~~financial ~~ET3M~~statement ~~have~~disclosure, ~~agreed~~or ~~that~~auditing ~~the~~scope ~~Joint~~or ~~Venture~~procedure, ~~Company~~which, ~~shall~~if ~~reinvest~~not atresolved ~~least~~to ~~during~~ the ~~first~~satisfaction ~~two years~~ of ~~existence~~Johnson, ~~all~~would ~~profits~~have ~~and~~caused ~~subsequent~~Johnson ~~thereto~~to ~~shall~~make ~~distribute~~reference onthereto anin ~~equal~~its ~~basis~~report byon ~~way of distributions not less than 20% of~~ the Company’s audited ~~after-tax net profit in relation to each~~ financial ~~year~~statements.

2The Company has provided Johnson with a copy of this Current Report on Form 8-K and has requested that Johnson furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not Johnson agrees with the statements made in this Current Report on Form 8-K with respect to Johnson and, if not, stating the aspects with which they do not agree. The Company has received the requested letter from Johnson wherein he has confirmed his agreement to the Company’s disclosures in this Current Report with respect to Johnson. A copy of Johnson's letter has been filed as an exhibit to this Current Report.

~~Dertek~~In ~~Joint~~connection ~~Venture~~with ~~Collaboration~~the ~~Agreement~~Company’s appointment of MB as the Company’s principal registered accounting firm at this time, the Company has not consulted MB on any matter relating to the application of accounting principles to a specific transaction, either completed or contemplated, or the type of audit opinion that might be rendered on the Company’s financial statements during the two most recent fiscal years (June 30, 2014 and 2013) and subsequent interim period through the date of engagement.

On February 20, 2015, the Board of Directors of the Company entered into that certain joint venture collaboration agreement dated February 20, 2015 (the "Dertek Joint Venture Agreement") with Tecnologia y desarrollo de energias renovables S.de R/L. de C.V. ("Dertek"), for the manufacture, distribution and marketing of Dertek's biofuel product. Dertek is a technology based company located in Mexico that has been developing a catalyst technology to produce a biofuel that could be used as a substitute for diesel fuel (the "Biofuel Technology"). After obtaining highly satisfactory pilot-test results, Dertek and the Company are moving forward into certified evaluations and scale up production of the Biofuel Technology. Management of the Company believes that the Biofuel Technology has demonstrated remarkable new properties as a fuel source. Therefore, the parties wish to establish a joint venture corporation (the "Joint Venture Corporation") called "Dertek International Technology Corp. USA" for the purpose of manufacturing, distributing and marketing of the Biofuel Technology and associated products commencing in the United States.2

~~The~~SECTION ~~general~~9 ~~purpose~~– ofFINANCIAL ~~the~~STATEMENTS ~~Dertek~~AND Joint Venture Agreement is to: (i) address international market opportunities for products based on the Biofuel Technology and provide fulfillment funding to manufacture and/or to license the Technology to third markets and to market the products; (ii) establish the Joint Venture Corporation for operational and funding requirements of the project and commitment of the Biofuel Technology; and (iii) establish a marketing and sales platform for the Biofuel Technology and associated products.EXHIBITS

In accordance with the terms and provisions of the Dertek Joint Venture Agreement, the parties agreed that certain contracts in acceptable form would be entered into as follows: (i) a distributorship agreement between Jonatan Hernandez Diaz ("Diaz") as the owner of the Biofule Technology and the Joint Venture Corporation relating to the distribution of the Biofuel Technology and associated products; (ii) a technology or patent rights transfer agreement between Diaz and the Joint Venture Corporation for the provision of the rights to the Biofuel Technology; (iii) a manufacturing agreement between certain manufacturers and the Joint Venture Corporation for the exclusive manufacturing of products associated with the Biofuel Technology; and (iv) a trademark license agreement between Diaz as the trademark owner and the Joint Venture Corporation for the licensing of the use of the Biofuel Technology and associated trademarks.

In further accordance with the terms and provisions of the Dertek Joint Venture Agreement, the parties agreed that the Joint Venture Corporation would be established for a period of twenty years, Dertek and the Company would each hold a 50% equity interest, respectively, and a four member board of directors shall be established with Dertek appointing two directors and the Company appointing two directors (and the removal of any one director shall require the votes of three directors). Dertek has committed to license to the Joint Venture Corporation the Technology and Dertek shall further assist the Joint Venture Corporation with: (i) product registration; (ii) efficacy UL and ASTM testing and qualifications; (iii) product summary descriptions and details; (iv) competitive industry and product review; (v) product pricing structure; (vi) market and sales stratgey and structure; (vii) manufacturing advice to produce samples and address initial purchase orders; (viii) building a marketing and sales team; (ix) identify and develop novel products to introduce to the marketplace that may generate source revenue; and (x) handle management and manufacturing personnel necessary to address sales and manufacturing.

The Company has committed to: (i) initiate a comprehensive process regarding the marketing, business development and sales of the Biofuel Technology and associated products; (ii) lead the entire process from consultation and design to delivery of the final business development team; (iii) provide fulfillment funding and marketing and sales platform; (iv) provide advance funding to execute fulfillment and all expenses related to contract, sampling, laboratory quality control testing, availabilty for finished product and any and all staffing.

Both the Company and Dertek have agreed that the Joint Venture Corporation shall reinvest at least during the first two years of existence all profits and subsequent thereto shall distribute on an equal basis by way of distributions not less than 50% of the audited after-tax net profit in relation to each financial year.

SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

Item 9.01 Financial Statements and Exhibits

(a) Financial Statements of Business Acquired.

Not applicable.

(b) Pro forma Financial Information.

Not applicable.

(c) Shell Company Transaction.

Not applicable.

(d) Exhibits.

10.1	Joint venture collaboration agreement dated February 28, 2015 between Nano Labs Corp. and The ET3M Group.
10.2	Joint venture collaboration agreement dated February 20, 2015 between Nano Labs Corp. and Tecnologia y desarrollo de energias renovables S.de R/L. de C.V.

16.1	Letter from Terry L. Johnson, CPA, dated May 14, 2015.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NANO LABS CORP.
Date: March 9, 2015	By:	/s/ Bernardo Camacho Chararria
Date: May 14, 2015	By:	/s/ Bernardo Camacho Chararria
	Name:	Bernardo Camacho Chararria
	Title:	President/Chief Executive Officer

Filing Compare · Nano Labs Corp.